Ua Cooperatief Atlantic General Net Worth & Insider Trades

Ua Cooperatief Atlantic General Centessa Pharmaceuticals Plc

As of July 5, 2022

What is Ua Cooperatief Atlantic General's Net Worth?

The current estimated net worth of Centessa Pharmaceuticals Plc's Ua Cooperatief Atlantic General is estimated to be about $33.11M . Ua Cooperatief Atlantic General owns about 9,681,818 units of Centessa Pharmaceuticals Plc common stock. In the last year at Centessa Pharmaceuticals Plc, Ua Cooperatief Atlantic General has sold an estimated value of $0 worth.

What is Ua Cooperatief Atlantic General's Past Insider Trading?

Ua Cooperatief Atlantic General's largest purchase order was 1,500,000 units , worth over $30M on June 3, 2021. In total, Ua Cooperatief Atlantic General has made about 2 transactions over a year of their time at Centessa Pharmaceuticals Plc. Ua Cooperatief Atlantic General usually trades in July and June, with the busiest year in 2022 and 2021.

GAP Bermuda LP, GENERAL ATLANTIC GENPAR BERMUDA LP, rl Sa Lux Atlantic General, SCSp Lux GenPar Atlantic General, General Atlantic Cooperatief LP, General Atlantic Partners Lux SCSp, General Atlantic Partners Bermuda EU LP, General Atlantic Partners Bermuda IV LP, UA Cooperatief Atlantic General, BV UM Atlantic General

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Ua Cooperatief Atlantic General's' Mailing Address?

  • Mailing address is Raamplein 1 Amsterdam P7 1016 XK Netherlands

What are Centessa Pharmaceuticals Plc's Past Insider Trades?

Centessa Pharmaceuticals Plc's most recent insider trade came on January 4, 2023 by Antoine Yver who sold 9,238 units worth $29.17K . In the last 2 years, insiders at Centessa Pharmaceuticals Plc have sold an estimated value of $1.52M and bought an estimated value of $75.13M worth of shares. Insider trading is most common in July, with the busiest year in 2022. The most active traders at the company are Antoine Yver, EVP & Chairman Development,  David Grainger, Chief Innovation Officer,  and Iqbal Hussain, General Counsel .

Centessa Pharmaceuticals plc Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1